Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00646646 · ClinicalTrials.gov registry record · NA
The Effect of Sedation on Eye Movements
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT00646646 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 65 participants.
The verdict
NCT00646646, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether sedation affects saccadic eye movements.
Interventions
- DRUG Midazolam
- DRUG saline placebo
- DRUG propofol
- DRUG dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00646646
The ClinicalTrials.gov registry entry for NCT00646646 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Midazolam is the first listed.
NCT00646646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00646646 about?
NCT00646646 is a clinical study titled "The Effect of Sedation on Eye Movements". The purpose of this study is to determine whether sedation affects saccadic eye movements.
What is the current status of trial NCT00646646?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2007-04. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00646646?
The interventions under investigation include: Midazolam (DRUG), saline placebo (DRUG), propofol (DRUG), dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00646646?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.